This trial evaluated the safety, tolerability, pharmacodynamics, pharmacokinetics and clinical activity of AstraZeneca’s ...

Growth is driven by the increasing prevalence of neurological disorders like Alzheimer's, Parkinson's, and schizophrenia, ...

DelveInsight’s “ Dermatomyositis Market Insight, Epidemiology, and Market Forecast – 2034 ” provides an in-depth analysis of the current landscape and future outlook of the DM market across major ...

AstraZeneca secured a fast approval of lung and breast cancer drugs with usually sluggish Japanese regulators, just months after scoring similar approvals in the West. The Japanese Ministry of ...

The FTSE 100 index closed up 24.59 points, 0.3%, at 8,875.22, just shy of its record closing peak of 8,884.92 posted last ...

The portfolio continues to invest in companies we believe are strong and improving and have improvement that is sustainable.

The FTSE 100 index closed up 24.59 points, 0.3%, at 8,875.22, just shy of its record closing peak of 8,884.92 posted last Thursday and the all-time high of 8,908.82, recorded in March. The FTSE 250 ...

Corvus' soquelitinib shows promise in oncology & autoimmune fields, with Phase 3 PTCL data as a key catalyst. Click here to ...

HSBC and Shell are the only two British companies in the top 100 of Forbes’ Global 2000, but its presence grows with 68 ...

On the currency front, sterling weakened as Bank of England easing bets rose following the release of the latest UK labor ...

New data shed light on the best strategies for managing patients who develop interstitial lung disease while being treated ...

Mr. Shah Coherent Market Insights Pvt. Ltd. + 12524771362 email us here Visit us on social media: LinkedIn Facebook X ...